EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Molecular modeling of some commercially available antiviral drugs and their derivatives against SARS-CoV-2 infection

Mohammad Arman, Safaet Alam, Rifat A Maruf, Ziaus Shams, Mohammad N Islam

Narra J · 2024

DOI: 10.52225/narra.v4i1.319 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Narra J, 2024. Verfasst von Mohammad Arman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, State University of Bangladesh, Dhaka, Bangladesh. Hauptthemen laut MEDLINE: Antiviral Agents, Molecular Docking Simulation. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Numerous prior studies have identified therapeutic targets that could effectively combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, including the angiotensin-converting enzyme 2 (ACE2) receptor, RNA-dependent RNA polymerase (RdRp), and Main protease (Mpro). In parallel, antiviral compounds like abacavir, acyclovir, adefovir, amantadine, amprenavir, darunavir, didanosine, oseltamivir, penciclovir, and tenofovir are under investigation for their potential in drug repurposing to address this infection. The aim of the study was to determine the effect of modifying the functional groups of the aforementioned antivirals in silico. Using the genetic optimization for ligand docking algorithm on software Maestro (version 11.1), the modified antivirals were docked onto ACE2 receptor, RdRp, and Mpro. Using QuickProp (Maestro v11.1), PASS (prediction of activity spectra for the substances), and altogether with SwissADME, the ADMET (absorption, distribution, metabolism, excretion, and toxicity) of the modified antivirals, as well as their bioavailability and the predicted activity spectra, were determined. Discovery studio software was used to undertake post-docking analysis. Among the 10 antivirals, N(CH3)2 derivative of darunavir, N(CH3)2 derivative of amprenavir and NCH3 derivative of darunavir exhibited best binding affinities with ACE2 receptor (docking scores: -10.333, -9.527 and -9.695 kJ/mol, respectively). Moreover, NCH3 derivative of abacavir (-6.506 kJ/mol), NO2 derivative of didanosine (-6.877 kJ/mol), NCH3 derivative of darunavir (-7.618 kJ/mol) exerted promising affinity to Mpro. In conclusion, the results of the in silico screenings can serve as a useful information for future experimental works.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsMolecular Docking SimulationHumansSARS-CoV-2Drug RepositioningCOVID-19 Drug TreatmentModels, MolecularCOVID-19Angiotensin-Converting Enzyme 2Pandemics

Stichwörter der Autor:innen

ACE2Antiviral derivativesMproRdRPSARS-CoV-2

Substanzen

Antiviral AgentsAngiotensin-Converting Enzyme 2ACE2 protein, human

Autor:innen und Institutionen

  • Department of Pharmacy, State University of Bangladesh, Dhaka, Bangladesh.
  • Department of Pharmacy, International Islamic University Chittagong, Chittagong, Bangladesh.
  • Pharmaceutical Sciences Research Division, Bangladesh Council of Scientific and Industrial Research (BCSIR), Dhaka, Bangladesh.
  • Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Dhaka, Dhaka, Bangladesh.

Zitieren

APA

Arman, M., Alam, S., Maruf, R. A., Shams, Z., & Islam, M. N. (2024). Molecular modeling of some commercially available antiviral drugs and their derivatives against SARS-CoV-2 infection. Narra J. https://doi.org/10.52225/narra.v4i1.319

Vancouver

Arman M, Alam S, Maruf RA, Shams Z, Islam MN. Molecular modeling of some commercially available antiviral drugs and their derivatives against SARS-CoV-2 infection. Narra J. 2024. doi:10.52225/narra.v4i1.319

BibTeX
@article{Arman2024,
  author = {Arman, Mohammad and Alam, Safaet and Maruf, Rifat A and Shams, Ziaus and Islam, Mohammad N},
  title = {Molecular modeling of some commercially available antiviral drugs and their derivatives against SARS-CoV-2 infection},
  journal = {Narra J},
  year = {2024},
  doi = {10.52225/narra.v4i1.319}
}
Kostenlos starten →